Bagby, RM, Ryder, AG and Cristi, C (2002) Psychosocial and clinical predictors of response to pharmacotherapy for depression. Journal of Psychiatry and Neuroscience 27, 250–257.
Beck, AT, Steer, RA and Brown, GK (1996) BDI-II: Beck Depression Inventory, 2nd Edn. Manual. San Antonia: The Psychological Corporation.
Chen, Q and Wang, S (2013) Variable selection for multiply-imputed data with application to dioxin exposure study. Statistics in Medicine 32, 3646–3659.
Collins, GS, Reitsma, JB, Altman, DG and Moons, KG (2015 a) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMC Medicine 13, 1.
Collins, GS, Reitsma, JB, Altman, DG and Moons, KG (2015 b) Transparent reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. Annals of Internal Medicine 162, 55–63.
Debray, TP, Damen, JA, Snell, KI, Ensor, J, Hooft, L, Reitsma, JB, Riley, RD and Moons, KG (2017) A guide to systematic review and meta-analysis of prediction model performance. British Medical Journal (Clinical Research Ed.) 356, i6460.
Furukawa, TA (2010) Assessment of mood: guides for clinicians. Journal of Psychosomatic Research 68, 581–589.
Furukawa, T, Konno, W, Morinobu, S, Harai, H, Kitamura, T and Takahashi, K (2000) Course and outcome of depressive episodes: comparison between bipolar, unipolar and subthreshold depression. Psychiatry Research 96, 211–220.
Furukawa, TA, Yoshimura, R, Harai, H, Imaizumi, T, Takeuchi, H, Kitamura, T and Takahashi, K (2009) How many well vs. unwell days can you expect over 10 years, once you become depressed? Acta Psychiatrica Scandinavica 119, 290–297.
Furukawa, TA, Akechi, T, Shimodera, S, Yamada, M, Miki, K, Watanabe, N, Inagaki, M and Yonemoto, N (2011) Strategic use of new generation antidepressants for depression: SUND study protocol. Trials 12, 116.
Goff, DC Jr., Lloyd-Jones, DM, Bennett, G, Coady, S, D'Agostino, RB, Gibbons, R, Greenland, P, Lackland, DT, Levy, D, O'Donnell, CJ, Robinson, JG, Schwartz, JS, Shero, ST, Smith, SC Jr., Sorlie, P, Stone, NJ, Wilson, PW, Jordan, HS, Nevo, L, Wnek, J, Anderson, JL, Halperin, JL, Albert, NM, Bozkurt, B, Brindis, RG, Curtis, LH, DeMets, D, Hochman, JS, Kovacs, RJ, Ohman, EM, Pressler, SJ, Sellke, FW, Shen, WK, Smith, SC Jr., Tomaselli, GF and American College of Cardiology/American Heart Association Task Force on Practice, G. (2014) 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129, S49–S73.
Henkel, V, Seemuller, F, Obermeier, M, Adli, M, Bauer, M, Mundt, C, Brieger, P, Laux, G, Bender, W, Heuser, I, Zeiler, J, Gaebel, W, Mayr, A, Moller, HJ and Riedel, M (2009) Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. Journal of Affective Disorders 115, 439–449.
Kanai, T, Takeuchi, H, Furukawa, TA, Yoshimura, R, Imaizumi, T, Kitamura, T and Takahashi, K (2003) Time to recurrence after recovery from major depressive episodes and its predictors. Psychological Medicine 33, 839–845.
Kato, T, Furukawa, TA, Mantani, A, Kurata, K, Kubouchi, H, Hirota, S, Sato, H, Sugishita, K, Chino, B, Itoh, K, Ikeda, Y, Shinagawa, Y, Kondo, M, Okamoto, Y, Fujita, H, Suga, M, Yasumoto, S, Tsujino, N, Inoue, T, Fujise, N, Akechi, T, Yamada, M, Shimodera, S, Watanabe, N, Inagaki, M, Miki, K, Ogawa, Y, Takeshima, N, Hayasaka, Y, Tajika, A, Shinohara, K, Yonemoto, N, Tanaka, S, Zhou, Q, Guyatt, GH and for the SUND Investigators (2018) Optimising first- and second-line treatment strategies for untreated major depressive disorder – the SUND study: a pragmatic, multi-centre, assessor-blinded randomised controlled trial. BMC Medicine 16, 103.
Katz, MM, Tekell, JL, Bowden, CL, Brannan, S, Houston, JP, Berman, N and Frazer, A (2004) Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression. Neuropsychopharmacology 29, 566–579.
Keller, MB (2003) Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. JAMA 289, 3152–3160.
Kessler, RC, van Loo, HM, Wardenaar, KJ, Bossarte, RM, Brenner, LA, Ebert, DD, de Jonge, P, Nierenberg, AA, Rosellini, AJ, Sampson, NA, Schoevers, RA, Wilcox, MA and Zaslavsky, AM (2017) Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder. Epidemiology and Psychiatric Sciences 26, 22–36.
Kroenke, K, Spitzer, RL and Williams, JB (2001) The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine 16, 606–613.
Little, RJ and Rubin, DB (2002) Statistical Analysis with Missing Data. New York: John Wiley & Sons.
Nierenberg, AA (2013) Strategies for achieving full remission when first-line antidepressants are not enough. Journal of Clinical Psychiatry 74, e26.
Nierenberg, AA and Wright, EC (1999) Evolution of remission as the new standard in the treatment of depression. Journal of Clinical Psychiatry 60(Suppl 22), 7–11.
Rabar, S, Lau, R, O'Flynn, N, Li, L, Barry, P and Guideline Development, G (2012) Risk assessment of fragility fractures: summary of NICE guidance. British Medical Journal (Clinical Research Ed.) 345, e3698.
Rubin, DB (1987) Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons.
Rush, AJ, Trivedi, MH, Wisniewski, SR, Stewart, JW, Nierenberg, AA, Thase, ME, Ritz, L, Biggs, MM, Warden, D, Luther, JF, Shores-Wilson, K, Niederehe, G and Fava, M (2006) Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. New England Journal of Medicine 354, 1231–1242.
Shimodera, S, Kato, T, Sato, H, Miki, K, Shinagawa, Y, Kondo, M, Fujita, H, Morokuma, I, Ikeda, Y, Akechi, T, Watanabe, N, Yamada, M, Inagaki, M, Yonemoto, N and Furukawa, TA (2012) The first 100 patients in the SUND trial (strategic use of new generation antidepressants for depression): examination of feasibility and adherence during the pilot phase. Trials 13, 80.
Spitzer, RL, Williams, JB, Kroenke, K, Linzer, M, deGruy, FV III, Hahn, SR, Brody, D and Johnson, JG (1994) Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 272, 1749–1756.
Sterne, JA, White, IR, Carlin, JB, Spratt, M, Royston, P, Kenward, MG, Wood, AM and Carpenter, JR (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. British Medical Journal (Clinical Research Ed.) 338, b2393.
Szegedi, A, Jansen, WT, van Willigenburg, AP, van der Meulen, E, Stassen, HH and Thase, ME (2009) Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. Journal of Clinical Psychiatry 70, 344–353.
Tadic, A, Helmreich, I, Mergl, R, Hautzinger, M, Kohnen, R, Henkel, V and Hegerl, U (2010) Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression. Journal of Affective Disorders 120, 86–93.
Wood, AM, White, IR and Royston, P (2008) How should variable selection be performed with multiply imputed data? Statistics in Medicine 27, 3227–3246.